Bile Duct Cancer (Cholangiocarcinoma)

Jaundice-driven diagnosis — drainage first, then local control of a central tumour.

Cancer

Bile Duct Cancer (Cholangiocarcinoma)

What is this cancer?

Cholangiocarcinoma arises in the bile ducts inside or outside the liver. It is often silent until a duct narrows, causing obstructive jaundice. Location — intrahepatic, perihilar or distal — determines the whole pathway.

Warning signs

  • Yellow skin and eyes, dark urine, pale stools and intense itching
  • Right upper abdominal discomfort and weight loss
  • Clay-coloured stools with steatorrhoea and fever

Diagnosis & staging

MRCP and contrast CT map the stricture; ERCP or percutaneous transhepatic cholangiography provides brushing/biopsy and can place a drain or stent. CA 19-9 and liver function guide preparation for treatment.

Treatment at St. Stamford

Drainage to restore bilirubin comes first. Our MDT then applies selective arterial infusion with DEB-TACE, CT-guided seed implantation along the duct, and Nanoknife for perihilar tumours encasing vessels — staged carefully with systemic therapy.

Why minimally invasive care

Image-guided ablation and embolization treat the tumour through millimetre-sized punctures, sparing healthy tissue and shortening hospital stay — often an option when surgery, age or prior treatment make open surgery risky.

Every pathway at St. Stamford is planned by a multidisciplinary team — interventional radiologists, medical oncologists and imaging specialists review your scans together. Send your reports before you travel and receive a written pathway in English.

Still have questions?

Reach our care team for personalized guidance on diagnosis, treatment, and insurance.

Request a Consultation
← Back to Cancer